Placing a soft transanal tube during rectal cancer surgery may reduce the need for further operations due to bowel leakage, though uncertainty remains regarding whether it lowers the overall leakage rate. Clinical studies show mixed outcomes, particularly when balanced against the use of a diverting stoma.
Among the most feared adverse events in colorectal surgery is anastomotic leakage—a failure of the newly reconnected bowel to heal properly. As medical teams evaluate adjunctive devices to protect these surgical sites, clinical interest has turned toward the transanal tube: a soft drainage catheter placed through the anal canal to relieve luminal pressure near the anastomosis.
Recent synthesis of clinical data up to August 2025 highlights both the potential benefits and the distinct operational risks of transanal drainage tubes. Understanding how these devices function, who they help, and where complications arise requires a close look at current surgical trials.
Understanding Anastomotic Leakage and Surgical Reconnections
When operating on rectal cancer, surgeons typically perform a low anterior resection or total mesorectal excision (TME), which is considered the gold standard procedure. Following the removal of the malignant tumor and surrounding mesorectal fatty tissue, the remaining ends of the bowel are surgically reconnected. This junction is known as the anastomosis.
If this connection fails to heal properly, intestinal contents can escape into the sterile abdominal cavity, triggering severe infection, prolonged recovery, or life-threatening sepsis. To mitigate this risk, clinicians traditionally rely on a diverting stoma—creating a temporary abdominal opening for stool to bypass the healing connection. However, stomas carry their own burden of complications and require a secondary closure operation.
As an alternative or adjunct, placing a soft transanal tube near the anastomosis aims to decompress intraluminal pressure and drain fluids before they stress the suture line. Yet, clinical consensus on its efficacy has remained nuanced.
In Plain English: The Clinical Takeaway
- The Device: A transanal tube is a soft catheter inserted through the anus to sit near the new bowel connection, venting gas and fluid to lower pressure.
- The Benefit: Available data suggests it may reduce the likelihood that a patient requires a secondary reoperation if minor healing issues occur, and it may shorten hospital stays.
- The Caveat: For patients who already have a temporary diverting stoma, using a transanal tube was associated with a higher frequency of leakage in reviewed studies.
Analyzing the Clinical Evidence and Trial Outcomes
An extensive evaluation of four controlled studies involving 1,318 adults undergoing rectal cancer surgery—conducted across centers in Denmark, China, and Japan—provides a clearer picture of these devices. Patients in these trials typically had a transanal tube in place for three to seven days.
The comparative data reveals subtle distinctions in patient outcomes:
| Postoperative Metric | Without Transanal Tube | With Transanal Tube |
|---|---|---|
| Risk of Anastomotic Leakage (per 1,000 patients) | 83 patients | 73 patients |
| Risk of Requiring Further Surgery (per 1,000 patients) | 45 patients | 14 patients |
| Average Hospital Discharge Timing | Baseline | Averages 3.25 days earlier (single-study data) |
While the absolute reduction in primary leakage rates appears modest, the reduction in reoperations is more pronounced across the analyzed cohorts. Furthermore, single-center retrospective analyses have explored transanal tubes in patients without stomas, noting potential utility in high-risk cohorts though underscoring the necessity for larger, prospective randomized trials.
Despite these promising signals, the data also highlights unwanted side effects. Approximately one in four patients reported localized pain or discomfort from the tube, and a small number experienced accidental dislodgement before the planned removal date.
Contraindications & When to Consult a Doctor
Not every patient undergoing colorectal resection is a candidate for a transanal drainage tube. Clinical trials demonstrate that patient selection dictates success. Specifically, individuals who receive a diverting stoma during their procedure experienced higher frequencies of leakage when a transanal tube was concurrently utilized, suggesting that the dual approach may be counterproductive or introduce mechanical irritation.
